dChan
Anonymous ID: 753d19 Feb. 26, 2020, 9:07 a.m. No.8255452   🗄️.is 🔗kun   >>5541 >>5718 >>5812

Extra Space Storage, Inc. Chairman sold: $21.53m-Feb 24-25

 

Extra Space Storage specializes in owning and managing self-storage facilities. Net sales break down by activity as follows:

  • rental of storage spaces (86.8%);

  • other (13.2%): tenant insurance, development and operation of storage facilities.

 

At the end of 2018, its real estate portfolio, with a total lettable area of 11,676,544.6 m2, was made up of 1,647 assets located in the United States and Puerto Rico.

 

Kenneth M. Woolley is the founder of our Company, served as our Chairman and CEO from our formation through March 2009, Chief Investment Officer from July 2012 to July 2013 and was formerly Chief Executive Officer of our predecessor. Mr. Woolley resigned from his position as Chairman and CEO of the Company effective April 1, 2009, to serve a voluntary three-year mission for his church, during which time he remained as a director. Mr. Woolley has been involved in the self-storage industry since 1977. He has been directly responsible for developing over 165 properties and acquiring over 625 self-storage properties throughout the United States. Early in his career he was a management consultant with the Boston Consulting Group. From 1979 to 1998, he was an Associate Professor, and later an Adjunct Associate Professor of Business Administration at Brigham Young University, where he taught undergraduate and MBA classes in Corporate Strategy and Real Estate. Mr. Woolley has also developed more than 13,000 apartment units through his Las Vegas entity, Nevada West Partners. He is also a partner in New York based Gaia Real Estate, which owns 16,500 apartment units and 600,000 square feet of office space. He has also founded several companies in the retail, electronics, food manufacturing and natural resources industries. Mr. Woolley currently serves as a trustee and a member of the compensation committee of American Homes 4 Rent. Mr. Woolley holds a B.A. in physics from Brigham Young University and an M.B.A. and Ph.D. in business administration from the Stanford Graduate School of Business.

https://ir.extraspace.com/board-member/kenneth-woolley

https://www.finviz.com/insidertrading.ashx?oc=1299642&tc=7

Anonymous ID: 753d19 Feb. 26, 2020, 9:28 a.m. No.8255592   🗄️.is 🔗kun   >>5718 >>5812

Regeneron Pharma. Inc, President/Chief Scientific Ofcr. sold: $49.63m-Feb 24

 

Regeneron Pharmaceuticals specializes in research, development, producing, and selling drugs used in treating ophthalmologic and inflammatory diseases and cancers. Sales break down by activity as follows:

  • sales of products (61.5%);

  • supply of collaborative services (33.3%): working with Sanofi (54.5% of sales) and Bayer (45.5%);

  • sales of technology licenses (5.2%). The group also provides subcontracting research services.

At the end of 2019, the group had a portfolio of 22 products in clinical development. Number of employees : 8 100 people.

 

https://www.finviz.com/insidertrading.ashx?oc=1226690&tc=7

 

-George Yancopoulos is the chief scientific officer of biotech firm Regeneron.

-He received his M.D. and Ph.D. from Columbia University and became a professor of biology by age 28.

-Regeneron was cofounded by now-billionaire Leonard Schleifer in 1988. Yancopoulos joined the next year.

-Yancopoulos led the invention of seven approved drugs and a technology platform designed to invent more.

>https://www.forbes.com/profile/george-yancopoulos/#7cb5cf785e10

 

Leonard S. Schleifer, MD, PhD, founded the Company in 1988, has been a Director and its President and Chief Executive Officer since its inception. He served as Chairman of the Board from 1990 through 1994. Dr. Schleifer, together with Dr. Yancopoulos, has grown Regeneron from a tiny startup into a ~$50 billion market cap company, with a unique science-driven culture, successful drug discovery and development engine and seven FDA-approved medicines. Dr. Schleifer has been recognized as one of Barron’s Best CEOs and as an Ernst & Young Entrepreneur of the Year. He graduated from Cornell University and earned his MD and PhD in Pharmacology from the University of Virginia. Dr. Schleifer is a licensed physician, certified in Neurology by the American Board of Psychiatry and Neurology, and worked as a practicing neurologist before founding Regeneron.

>https://www.regeneron.com/leadership